Delivery Order SPE2DB20D3104-SPE2DB21FV8T3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies. The contract, valued at $1,950.85, is a delivery order under a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 held by Amerisourcebergen's parent company, Cencora, Inc. This IDC serves as the primary vehicle for Amerisourcebergen to deliver essential medical...
- This federal contract award, with a value of $1,379.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,338.42 delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,800.46, is a delivery order for pharmaceutical products and medical supplies to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999 through November...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) for the delivery of a wide range of pharmaceutical products and medical supplies. The contract, valued at $12,790.61, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide essential...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,484.01, is a delivery order that falls under a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen). This IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,784.23 delivery order contract covers the provision of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,507.63 delivery order is for the provision of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care materials. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $76,982.68, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with a potential value of up to $999,999,999.00, which was awarded to Amerisourcebergen's parent company, Cencora, Inc., to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,134.16, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB21FV8T3Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a broad range of pharmaceutical products and medical supplies. The contract, valued at $1,937.40, is a delivery order under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc. This IDC serves as the primary vehicle for Amerisourcebergen to deliver essential medications, medical devices, and other healthcare commodities to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's expertise in pharmaceutical distribution and its extensive supply chain capabilities enable it to efficiently fulfill the government's diverse medical procurement needs across multiple therapeutic areas, including specialty drugs, brand-name pharmaceuticals, generic medications, and critical care supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/13/21 |